Impact of Radiofrequency Ablation and Antiarrhythmic Medications on the Quality of Life of Patients with Supraventricular Tachycardias: Preliminary Validation of the Greek Version of the Umea22 (U22) Questionnaire

Table 6

Multivariate linear regression analyses of the change in Umea22 measures at follow-up vs. baseline^∗.

Measures	Mean change±SD	Category	Coeff. (95% CI)	P
Arrhythmia events affect well being	-2.64±3.16
Group		A vs B	-4.10 (-5.03, -3.16)	<0.0001
Occupation		Employed vs other	1.18 (0.15, 2.21)	0.025
Fatigue	-0.23±2.83
Group		A vs B	-1.19 (-2.21, -0.16)	0.024
Sex		Male vs Female	-1.73 (-2.75, -0.72)	0.001
Fear to others	-1.40±2.96
Group		A vs B	-2.41 (-3.43, -1.40)	<0.0001
Residence		Urban vs other	-1.31 (-2.26, -0.36)	0.008

multivariate linear regression analyses of all other measures (not shown), Group was the only statistically significant predictor (p<0.0001 in all analyses), except for items 13 (heartbeat speed) and 14 (heartbeat intensity), where no statistically significant predictor emerged.